Phesi

Company profile

About Phesi

Phesi is a global provider of patient-centric data science solutions for clinical development, serving pharmaceutical and life sciences companies. The company's award-winning Trial Accelerator™ platform is powered by the world's largest clinical trials database, containing real-world data from over 325 million patients across 232 countries and territories, drawn from 719,183 clinical research projects and 22 global registries. Phesi's AI-driven solutions enable sponsors to optimize protocol design, create Digital Patient Profiles and Digital Twins, select high-performing investigator sites and countries, and generate Digital Trial Arms as external controls. By connecting real-world patient data with trial execution data, Phesi helps life sciences companies eliminate costly trial failures and protocol amendments, improve patient population accuracy and diversity, reduce trial timelines and patient burden across every stage of clinical development for any indication, including rare diseases. The company's proprietary integrated methodology and AI technologies analyze over 485,000 curated clinical trials, 4.2 million physicians, and 4,000+ disease indications. Phesi's approach transforms clinical development into a data-driven science, enabling predictive modeling across four key views: Patient Profile, Trial Performance, Country, and Investigator Site. The platform generates reliable evidence for drug development and commercialization without the expense or time required in traditional trials, helping pharmaceutical companies make more informed decisions and accelerate the path from research to market.

Company description · Phesi official website